Keeping the US reciprocal tariffs and its future impact on Indian businesses in mind, Union Commerce and Industry Minister, ...
Under the Biden administration proposal unveiled last November, an estimated 3.4 million Americans on Medicare would be eligible in 2026 for the drugs, which carry a list price of more than $1,000 a ...
What’s noteworthy is that in this Congress the Senate Judiciary Committee has voted to advance their drug patent reform plans ...
Imagine finally finding a pharmacy that doesn't drain your bank account—only for prices to suddenly spike. That's the situation Mark Cuban's Cost Plus Drugs might face, thanks to new tariff policies ...
Eli Lilly (NYSE: LLY) and Veeva Systems (NYSE: VEEV). Here's what investors need to know about these market leaders that ...
Indianapolis Zoo and Eli Lilly are part of a push to move medical industry away from using horseshoe crab blood and towards ...